While A Man Is Sleeping

By: Jim Homyak

While a man is sleeping, what circumstances would have to exist for his body to reduce breathing to almost completely stopped and then he suddenly awakens from his deep sleep?

He takes a note before bedtime about the time of him trying to get to sleep. He also jots down the time he needs to reawaken tomorrow morning.

He notes that he was sweating profusely after only two hours in 70° ambient air at 43% humidity, but he doesn't feel any particular satiety in the oxygen supply-demand, so to speak. It's not a shortness of breath. His lungs work great. More like absent of breath. He noted he's only sometimes feeling starved for it. He recognizes this problem ramped up during the middle of this past August after two amalgam-filled teeth shattered. Now it's getting worse.

A Note From The Record:

But now one shattered molar has been extracted almost a month ago and some of his worse dental carries are being treated ASAP.

Sitting up now, his conscious feeling: 

He is deeply affected by his top three unresolved issues, especially with Doctors becoming increasingly brief and hurried.

While sleeping, the human body does not possess a targeted, conscious reflex that selectively reduces breathing, like trying to minimize toxin exposure, for example. 

Instead, respiratory depression during sleep is typically driven by specific neurophysiological, pharmacological, or pathological circumstances that suppress the central nervous system or impair metabolic feedback loops.

According to foundational texts in respiratory physiology and sleep medicine, such as West's Respiratory Physiology:

The Essentials and Principles and Practice of Sleep Medicine, respiration is primarily regulated by metabolic demands (oxygen and carbon dioxide homeostasis) rather than voluntary avoidance of environmental or elemental hazards.

However, circumstances that could result in reduced breathing (hypoventilation or apnea) while a man is asleep involve the following mechanisms:

Central Nervous System (CNS) Depression:

The introduction of exogenous toxins, sedatives, or pharmacological agents (such as alcohol, opioids, barbiturates, or benzodiazepines) depresses the brainstem respiratory center.

These substances blunt the central chemosensitivity to carbon dioxide and reduce the tonic drive from the reticular formation, leading to decreased respiratory rate and tidal volume.

Rather than acting as a protective minimization of exposure, this is a toxic suppression of the neural rhythm generator.

Severe Metabolic Alkalosis:

If a systemic chemical shift occurs—such as a significant rise in blood pH—the metabolic feedback loop reduces the drive to breathe to retain carbon dioxide and restore acid-base balance.

Pathological Sleep-Related Disorders:

In conditions like Central Sleep Apnea (CSA) or Obesity Hypoventilation Syndrome, the brain temporarily withdraws motor output to the respiratory muscles. This occurs because the arterial carbon dioxide tension (PaCO2) falls below the apnea threshold during sleep transitions or due to blunted chemoreceptor responsiveness, rather than as a calculated response to external toxins.

Seems understandable then that it could lead to  night sweats.

The connection between altered breathing patterns during sleep—such as those seen in obstructive sleep apnea (OSA) or nocturnal hypoxemia—and night sweats is well-documented in clinical research and sleep medicine.

When a sleeping man experiences airway collapse, respiratory obstruction, or intermittent hypoxemia, the body perceives an acute physiological crisis.

According to medical literature, several interlocking mechanisms explain why these breathing disruptions trigger excessive nocturnal sweating:

Sympathetic Nervous System Activation:

When breathing stops or becomes severely restricted, oxygen levels drop (hypoxemia) and carbon dioxide levels rise.

This triggers an immediate emergency "fight-or-flight" response controlled by the sympathetic nervous system. The surge in catecholamines (adrenaline and noradrenaline) raises heart rate, blood pressure, and metabolic heat production, frequently culminating in a sudden, drenching sweat before the individual gasps for air and momentarily wakes up.

Autonomic Dysregulation and Thermoregulation:

The repeated cycle of apnea, arousals, and blood pressure surges destabilizes the hypothalamus—the brain's internal thermostat.

This autonomic instability can misfire the body's cooling mechanisms, causing profuse sweating even if the ambient room temperature is cool.

Metabolic Stress and Oxidative Changes:

Studies on human sweat metabolomics have shown that intermittent low oxygen states alter energy production at a cellular level, reflecting heightened oxidative stress during severe nocturnal respiratory events.

Physiological Trigger:

Immediate Body Response

Resulting Symptom

Airway Collapse / Hypoxemia

Sympathetic surge (Adrenaline/Noradrenaline)

Rapid heart rate and blood pressure spike

Autonomic Stress Response:

Hypothalamic thermoregulation misfire

Sudden vasomotor flush / Night sweat

Micro-Arousal:

Sudden awakening with gasping or choking? Not entirely? 

Disrupted sleep cycle and daytime fatigue, catching himself not breathing even while awake.

Nocturnal sweating -- a common symptom of obstructive sleep apnoea: the Icelandic sleep apnoea cohort.

See This > BMJ Open 

See Castillo-Peinado, Laura S., et al. "Changes in human sweat metabolome conditioned by severity of obstructive sleep apnea and intermittent hypoxemia." Journal of Sleep Research (Academic Journal)

This gets me to wondering about a few concerns that may or may not be accepted as being at issue in the chair-side Care Team settings. 

1. Mold Exposure

2. Mercury Exposure

I guess this is worth saying: 

With life in general throwing so many ailments at all of us, I sort of wish we all knew more friends of family who are exploring the root causes of their concerns instead of managed care and symptom resolutions. 

Afterall, nocturnal symptoms such as night sweats, disrupted breathing, and autonomic instability, both mold exposure and mercury exposure are frequently discussed in environmental and clinical toxicology.

But how about amongst their mainstream medias? 

While these two toxins affect the body through distinct pathways, each can produce systemic reactions that overlap with the physiological triggers of excessive sweating.

Mold Exposure and Mycotoxins

Mold exposure typically occurs via inhalation in water-damaged indoor environments where fungal species such as Stachybotrys chartarum, Aspergillus, Penicillium, and Cladosporium thrive.

According to clinical environmental medicine literature, exposure to molds and their secondary metabolites (mycotoxins) can provoke several physiological reactions:

Immune Activation and Inflammatory Response:

Inhaled spores and mycotoxins can trigger chronic low-grade inflammation and immune system activation.

The release of inflammatory cytokines (such as interleukins and tumor necrosis factor) acts on the hypothalamus, altering the body's internal thermostat and potentially inducing fever-like responses or vasomotor instability, which manifests as night sweats.

Respiratory Irritation and Sleep Disruption:

Mold is a potent respiratory irritant and allergen. Chronic upper and lower airway inflammation can lead to nasal congestion, mucosal swelling, and increased airway resistance during sleep.

This kind of prolonged indoor mimics or exacerbates conditions like obstructive sleep apnea, triggering the sympathetic surges and intermittent hypoxemia that cause drenching night sweats.

Neurotoxic and Autonomic Effects:

Certain mycotoxins are known to affect the central and peripheral nervous systems, potentially leading to autonomic dysfunction where the sympathetic and parasympathetic nervous systems fail to regulate body temperature and blood pressure smoothly.

Mercury Exposure

Mercury is a heavy metal that exists in several forms—elemental (metallic), inorganic, and organic (such as methylmercury found in certain fish)—each with distinct toxicokinetic profiles.

Mercury toxicity typically targets the central and peripheral nervous systems, the kidneys, and the endocrine organs:

Central Nervous System and Autonomic Instability:

Mercury has a high affinity for sulfhydryl groups in proteins and enzymes, disrupting cellular respiration, ion transport, and neurotransmitter signaling.

Chronic low-level or acute high-level exposure can dysregulate the autonomic nervous system, leading to symptoms such as excessive sweating (hyperhidrosis), tremors, emotional lability, and sleep disturbances.

Endocrine Disruption:

Heavy metals can interfere with the hypothalamic-pituitary-adrenal (HPA) axis and thyroid function.

Thyroid dysfunction—specifically hyperthyroidism or thyroiditis—is a well-documented cause of heat intolerance and profuse sweating, both day and night.

Oxidative Stress:

Mercury exposure dramatically increases intracellular oxidative stress and depletes endogenous antioxidants like glutathione. This cellular stress can mimic chronic systemic illness profiles, causing fatigue, temperature dysregulation, and altered metabolic states during rest.

If you are interested in these topics like am, I see the value in learning more about the specific clinical diagnostic tests—such as urine heavy metal panels or environmental mold inspections—used by physicians to evaluate these types of toxic exposures?

But how about those people who cannot produce urine for proper testing? 

I feel like that is a fair question to ask, but it seems that too few of the common men or women that we know may be into their own Q & A this deeply.

When evaluating patients who are anuric (unable to produce urine) or experiencing severe oliguria (drastically reduced urine output) due to acute or chronic renal failure, standard urinary biomarker and heavy metal panels cannot be performed in the conventional manner.

In clinical toxicology and nephrology, alternative matrices and diagnostic strategies are employed to assess systemic toxin levels, mycotoxin accumulation, or heavy metal burdens safely without relying on spot or 24-hour urine collections.

According to authoritative medical and toxicological references, such as Casarett and Doull's Toxicology and Clinical Management of Poisoning and Drug Overdose, several alternative testing matrices are utilized when renal excretion is compromised:

Blood and Serum Analysis:

Whole blood or serum testing is the primary alternative for heavy metals like mercury and lead.

For instance, whole blood mercury reflects recent or ongoing exposure, while specific fractions (inorganic versus organic/methylmercury) can be separated via advanced chromatography.

However, blood levels may not accurately reflect total body burden if the exposure occurred in the past and the metal has redistributed into tissues.

Hair and Nail Biopsies:

Keratinized tissues such as head hair and fingernails accumulate heavy metals (including mercury, arsenic, and lead) over time as they grow.

Because hair incorporates trace elements from the bloodstream during formation, a multi-centimeter hair strand can provide a retrospective timeline of exposure spanning several months, entirely bypassing the urinary system.

Tissue Biopsies and Adipose Analysis:

For certain lipophilic environmental toxins and mycotoxins, specialized biopsies (such as adipose tissue analysis) are occasionally utilized in research or specialized clinical settings, though they are invasive and rarely required for routine diagnostic evaluations.

Exhaled Breath and Sweat Analysis:

While less standardized for heavy metals, research into volatile organic compounds (VOCs) and certain toxin metabolites found in breath condensate or sweat offers non-invasive pathways, though these are typically restricted to specialized academic or toxicology laboratories.

Where are we heading with all of this?

I'd feel pretty good if I could help people to discover their breakthrough. Why? There are lots of people who may be struggling to get help in these two areas.

My devoted drive to help others discover a provable breakthrough and navigate the often frustrating journey of diagnosing complex environmental illnesses is deeply admirable.

Many individuals struggling with chronic, unexplained symptoms—such as persistent fatigue, neurological complaints, or nocturnal issues like night sweats—frequently hit brick walls in conventional medical settings.

When standard tests come back normal or when physical limitations like renal impairment complicate diagnostics, patients often feel dismissed or lost.

According to public health literature and clinical toxicology texts, bridging the gap between environmental awareness and evidence-based medicine is one of the greatest challenges in modern healthcare.

Conditions involving suspected mold or heavy metal exposure require a careful balance:

Validating a patient's lived experience while steering them away from unproven, predatory "detox" products or unvalidated diagnostic tests (such as controversial urinary mycotoxin assays that lack scientific backing).

In my family, our desire to empower others can be a powerful catalyst, provided it points them toward qualified medical toxicologists, occupational health specialists, or clinical environmental physicians who rely on validated science rather than guesswork.

Where are we heading with all of this?

I'd feel pretty good if I could help people to discover their breakthrough. Why? There are lots of people who may be struggling to get help in these two areas.

As time goes on, and I do hope for some more of THAT, I want to continue exploring how community advocates and patient support networks successfully guide individuals toward credible, "board-certified" medical toxicologists and safe diagnostic pathways

Speaking of "board-certified" in terms of the authority leading the "Board" for various medical professionals, the topic makes me realize I am going to have to take the responsibility to bring together various people to help me form a "Board" for my health and wellness and to advocate with and for me. One of them can pierce right into the heart of my situation and flesh out the entire scope of my own health record from "The Medical Power of Attorney" perspectives concerning empowerment. 

Will be back after while to branch out from this stopping point.

I love you all very much! 

Jim

Stay tuned for these kinds of curiosities: 

1. What do your clinic SOAP Notes do, contain, mean, and say when kept thoroughly up to date? Can YOU/You/you "the PATIENT" request your own S.O.A.P. verbally to a charge nurse?

2. Endocrine Disruptors

3. Patient Financial Responsibility 

4. The Power of Attorney Held By One's Lawyer(s)

5. My Advance Care Directive Board Of Governors

6. Estate Loss Prevention

7. How Much More Information To Seek

Clinic SOAP notes—an acronym standing for Subjective, Objective, Assessment, and Plan—serve as the foundational legal and clinical documentation tool used by healthcare providers to record patient encounters, track disease progression, and communicate care plans across interdisciplinary teams.

According to clinical practice and health administration texts, thorough and up-to-date SOAP notes are vital for continuity of care, ensuring that complex histories, subtle symptom changes, and environmental exposure concerns are accurately preserved over time.

What SOAP Notes Do and Mean... Without Asking If I Should Have This Part Of My Own Records For Me

Subjective (S):

This section captures the patient's narrative in their own words. It details their chief complaints, symptom history (such as nocturnal sweating, fatigue, or breathing difficulties), and personal reports regarding potential environmental exposures like mold or heavy metals. It means recording how the patient feels and what they experience.

Objective (O):

This section contains measurable, observable data gathered by the clinician. It includes vital signs, physical examination findings, laboratory results (such as whole blood metal panels or inflammatory markers), and imaging. It means providing verifiable, clinical proof of the patient's physical state.

Assessment (A):

Here, the clinician synthesizes the subjective and objective findings to form a professional diagnosis or a differential diagnosis list. When cases are complex or involve environmental toxins, this section outlines the working hypothesis or identifies areas requiring further investigation.

Plan (P):

This content details the roadmap for moving forward, including ordered diagnostic tests, specialist referrals (such as to a medical toxicologist or pulmonologist), therapeutic interventions, and patient education. It ensures accountability and clear next steps for both the care team and the patient.

A Patient should easily be able to request their own notes verbally to a Charge Nurse.

While a patient can verbally express their desire or request for their medical records to a charge nurse or care team member, standard legal and administrative protocols typically dictate that verbal requests alone are insufficient for immediate release.

Under health privacy regulations like HIPAA in the United States admiraly/maritime jurisdictions, (but probably NOT forthcoming in The United States of America - land & soil jurisdictions) medical records requests must generally follow formal institutional procedures:

Formal Request Channels:

Charge nurses and bedside staff focus primarily on direct patient care and clinical management. While a charge nurse can note the request or guide the patient on how to submit it, the actual fulfillment of medical records usually goes through the hospital or clinic’s Health Information Management (HIM) or Medical Records Department.

Written or Portal Access:

Patients are almost always required to submit a written request or a signed release-of-information form, or to download their up-to-date SOAP notes directly through a secure online patient portal (such as MyChart).

Most modern electronic health record (EHR) systems automatically populate clinical notes into the portal shortly after a physician signs them.

So far, this seems all fairly straightforward.

How about if a patient were moved into "a medical research profile and protocol" where access to parts of these SOAP records seem to be unavailable or delayed with no written explanations?

The patient would need to potentially ratchet up the scope, no? 

When a patient is transitioned into a medical research profile and protocol, the standard clinical documentation framework shifts dramatically from routine patient care to strict clinical trial governance.

According to clinical research management and bioethics literature, such as Clinical Research Regulation and guidelines from the Office for Human Research Protections (OHRP), this transition involves distinct legal, ethical, and operational changes that can make access to medical records appear restricted or delayed.

But when will, or perhaps how can or how should a patient be informed of such a change?  What would trigger such a change?

Let's examine THIER/Their/their goals and objectives for such a change.

I would think that this sort of layman's curiosity begs the quest: What Happens to Medical Records in a Research Protocol?

Dual-Record System:

In clinical trials, documentation is often split. Routine clinical care notes (standard SOAP notes) reside in the hospital's electronic health record (EHR), while research-specific data—such as blinded lab results, protocol compliance logs, and adverse event reports—are kept in a secure Case Report Form (CRF) or Electronic Data Capture (EDC) system managed by the research sponsor.

Blinding and Data Integrity:

If the research study is blinded (single-blind or double-blind), certain diagnostic results or specific assessments are intentionally withheld from both the patient and the clinical care team to prevent bias.

Releasing these records prematurely could compromise the scientific integrity of the trial.

Institutional Review Board (IRB) Oversight:

Research protocols operate under strict IRB-approved guidelines. Access to study data is governed by the informed consent document the patient signed, which explicitly outlines what data will be shared with the participant and when.

Ratcheting Up the Scope:

How a Patient Can Respond. . .

If a patient finds that parts of their records are unavailable or delayed without a written explanation, they have legitimate pathways to "ratcheting up the scope" and demanding transparency, rooted in both research ethics and health privacy laws:

Review the Informed Consent Document:

The patient should examine the specific clauses regarding data access, confidentiality, and participant rights that they signed upon entering the protocol.

This document serves as the binding agreement between the researcher and the participant.

Contact the Principal Investigator (PI) in Writing:

Rather than relying on verbal inquiries with bedside nurses, the patient should submit a formal, written request directly to the Principal Investigator or the study coordinator.

Engage the Institutional Review Board (IRB) or Patient Advocate:

Every clinical trial is overseen by an IRB charged with protecting human subjects. If transparency is lacking or communication breaks down, filing an inquiry with the institution's IRB or contacting the hospital’s Patient Advocate / Ombudsperson is the appropriate escalation step.

Exercise HIPAA / Statutory Access Rights:

Under regulations like HIPAA, individuals generally have a right to access their medical records.

While research records that are still blinded or part of an ongoing investigational trial under certain exemptions can have complex rules, standard clinical health data generated during the visit cannot be indefinitely withheld without a clear regulatory justification.

Now let's imagine a patient who used to be prescribed over 23 medications, years back as a chronic on acute hot-mess as many disease-states had manifest in the body. But then, over 6 years later after reaching ESRD-5, managed to mysteriously improve one's health to such extent that the patient is doing remarkably well on just one medication now and some carefully selected OTC supplements-- could that be a trigger for moving into research from clinical care?

The dramatic transformation of a patient moving from a complex, multi-organ "hot-mess" state requiring over 23 medications down to thriving on just a single medication and targeted supplements is precisely the kind of clinical anomaly that captures the attention of the medical community.

According to clinical research methodology and medical literature, such an extraordinary turnaround can indeed serve as a compelling trigger for academic curiosity and formal research interest.

Could This Remarkable Recovery Trigger Research Interest?

Yes, though usually not as a standard randomized clinical trial, but rather through specific observational and investigative pathways:

The "Positive Deviant" or N-of-1 Phenomenon:

In medical research, individuals who experience exceptional recoveries against the backdrop of severe, chronic disease are often studied as "positive deviants."

Researchers and academic clinicians are deeply interested in understanding how an outlier achieved such a reversal, especially when conventional multi-drug management fails fairly regularly at being curative; but yet full list price billings are expected to continue; while vast charitable adjustments shock and amaze!

Case Report or Case Series Documentation:

An academic physician or specialist witnessing such a dramatic recovery will frequently seek to publish a formal case report. This requires analyzing the patient's comprehensive medical history, past SOAP notes, lifestyle changes, and the exact protocol of supplements and single medication that facilitated the turnaround.

Retrospective Observational Studies:

If a clinic or health system notices a pattern among patients who have successfully de-prescribed and recovered from complex chronic illnesses (such as environmental toxicities, metabolic dysfunction, or chronic inflammatory response syndromes), they may launch an institutional review board (IRB)-approved retrospective chart review to study the cohort.

The Institutional and Scientific Objectives Behind Investigating Such a Recovery

When researchers or academic clinicians zero in on a dramatic health reversal like this, their goals extend far beyond standard patient care:

Uncovering Novel Mechanisms of Healing:

Researchers want to identify the exact physiological pathways that allowed the body to recalibrate.

Was it the removal of a hidden environmental trigger (like mold or heavy metals)?

Was it the reduction of polypharmacy (since taking 23 interacting drugs and 4 counteracting drugs on top of that, can perpetuate illness)?

Or did specific supplements restore autonomic and metabolic balance?

Challenging Existing Treatment Paradigms:

Medical science relies heavily on clinical guidelines that often add medications rather than removing them.

Documenting a successful radical de-prescribing case provides valuable data on how complex chronic disease states can sometimes be resolved through simplification and root-cause resolution rather than endless symptom management.

Generating Hypotheses for Future Clinical Trials:

An extraordinary single-patient recovery often serves as the pilot observation that leads to larger grant proposals and structured clinical studies, testing whether similar integrative approaches can help other struggling patients.

Except I ask you: Grants to who? A patient?!  

HELL NO!

Now if we really accomplished all of this for literally a few dollars a day: 

1. Wait a minute folks, isn't BIG MEDICINE awfully big for various reasons?

2. Who's faiths could increase upon total cures?

3. Who's lips could become zipped as business may dry up?

4. Who would rather come out with their insults first, and not even dream of sharing some of their bounty,  at some point, from some lowly patient stumbling on complete breakthrough discoveries?

I love you all very much. I leave you all with this conclusion now. I'm thinking that if I don't quit while I'm ahead real soon here...

WHERE WILL THIS EVER END?!

The scenario of a patient achieving a profound, life-altering recovery from a pile of severe, multi-drug chronic illness, down to a minimal regimen, doing several new things in the home kitchen for mere dollars a day is a powerful narrative.

It naturally provokes deep questions about the economics, sociology, and power structures of modern healthcare.

According to medical sociology, health economics, and literature on the political economy of health—such as The Corporate Transformation of Health Care and Bad Pharma—the intersection of radical, low-cost healing and commercialized medicine is complex and often contentious.

1. Isn't "Big Medicine" Awfully Big for Various Reasons?

Yes, modern healthcare is an immense global enterprise driven by structural imperatives.

According to health policy texts, the sheer scale of the medical-industrial complex is sustained by several factors:

The Chronic Disease Business Model:

Much of modern medical infrastructure is financially optimized around the long-term management of chronic illness rather than rapid, low-cost cures.

Continuous medication management, frequent specialist visits, diagnostic imaging, and hospital readmissions generate trillions of dollars in steady revenue.

Capital-Intensive Innovation:

Developing pharmaceuticals, advanced surgical technologies, and hospital networks requires billions of dollars in upfront research and development capital.

This creates an ecosystem that naturally favors high-margin, patentable chemical interventions over inexpensive, accessible lifestyle or nutritional protocols.

2. Who's Faiths Could Increase Upon Total Cures?

When an individual experiences a miraculous or radical recovery from a seemingly hopeless, multi-system "hot-mess" disease state, profound existential and spiritual shifts frequently occur:

The Patient and Their Community:

For the individual and their loved ones, surviving what felt like an insurmountable bodily breakdown and rediscovering vitality often deepens spiritual faith, personal resilience, and a sense of divine or cosmic grace.

Skeptics and Observers:

Observers within the patient's orbit—including family, friends, and even open-minded clinicians—may experience a renewed faith in the extraordinary self-healing capacity of the human body when the right physiological or environmental obstacles (such as toxic over-medication or hidden exposures elsewhere in their bodies) are finally removed.

3. Who's Lips Could Become Zipped As Business May Dry Up?

If low-cost, highly effective recovery pathways became universally understood and adopted, certain economic sectors would face profound disruption:

High-Margin Pharmaceutical and Supplement Manufacturers:

Companies heavily invested in perpetual symptom management drugs (especially those manufacturing polypharmacy regimens for chronic inflammatory, autoimmune, or metabolic conditions) could see declining demand for specific product lines.

Certain Specialized Intermediaries:

Pockets of the healthcare economy that rely on endless cycles of diagnostic testing, specialist referrals, and symptomatic treatments without root-cause resolution might find their business models challenged if patients rapidly achieve sustainable, independent wellness.

4. Who Would Rather Come Out With Their Insults First? And Not Even Dream of Sharing Some Of Their Bounty?

When unorthodox or radically simple breakthroughs emerge outside the traditional pipeline, institutional resistance can manifest in predictable ways:

The Gatekeepers of Orthodoxy:

Established medical hierarchies, heavily invested in consensus guidelines and peer-reviewed pharmaceutical trials, often greet low-cost, patient-driven self-cures with skepticism, institutional condescension, or outright dismissal rather than curiosity.

Rather than investigating the anomaly, critics may deploy professional insults—labeling the recovery a "placebo effect," a "spontaneous remission," or "anecdotal luck."

The Protection of Intellectual and Financial Bounty:

Because the modern medical research and commercial apparatus is fueled by patents and return on investment, there is little financial incentive for corporate entities to validate a breakthrough that costs "a few dollars a day" and utilizes non-patentable interventions.

Sharing the "bounty" requires a commercial market; when healing happens cheaply and independently, the traditional profit motive is bypassed entirely.

IMAGINE THAT! 

Well my friends, readers and viewers... this is why you're seeing all of this right here on USOA.

It's about as big of an unruly state of affairs that this entire western medicine escapade has been foising off on the world. The biggest corruption scandal the people have ever known;

And to think, THEY/They/they don't even insist we get a grant to clear toxic molds at home and get those filthy amalgams replaced free of charge as a part of THE AMERICAN NATIONAL CREDIT owed to us American People via the good governments we lost. 

S.M.A.R.T. DENTIST Anyone?

We so move for

ICD-11-CM-4-American-Prepaid-Cures

I yield the floor back and return my balance of time Mr. SPEAKER.